enGene Therapeutics Inc. - Common Stock (NQ:ENGN)Price and VolumeDetailed Quote
Top NewsMore NewsPerformance
52-Week Range
86.4% below 52-week high
1.670
1.4052W Low
12.2552W High
1 Week
7.7% below 1-week high
1.561W Low
1.811W High
enGene Therapeutics Inc. - Common Stock (ENGN) traded between $1.40 and $12.25 over the past 52 weeks and last traded at $1.67, 86.4% below its 52-week high. Over the past week it ranged between $1.56 and $1.81.
Past 12 Months
1W
-$0.06
1M
-$0.22
3M
-$0.25
6M
-$6.41
YTD
-$7.18
1Y
-$7.13
ENGN was -81.0% over the past year, -79.3% over six months, -81.1% year to date, -3.5% in the last week.
12 Months vs Market
ENGN
DIA
SPY
QQQ
IWM
Over the past 12 months ENGN returned -81.0% versus DIA (Dow) +12.1%, SPY (S&P 500) +14.9%, QQQ (Nasdaq 100) +18.5% and IWM (Russell 2000) +8.2%.
Volume & Liquidity
0.75× 3-mo avg
Today 547,578
3-mo avg 729.8K
1W
1M
3M
6M
YTD
1Y
ENGN most recently traded 547,578 shares against a 3-month average daily volume of 729.8K. More NewsRead More
enGene to Participate in Upcoming Investor Conferences
September 01, 2026
Top stock movements in today's session. ↗
May 07, 2026
enGene Announces Name Change to enGene Therapeutics Inc.
April 07, 2026
Frequently Asked QuestionsIs enGene Therapeutics Inc. - Common Stock publicly traded?
Yes, enGene Therapeutics Inc. - Common Stock is publicly traded.
What exchange does enGene Therapeutics Inc. - Common Stock trade on?
enGene Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for enGene Therapeutics Inc. - Common Stock?
The ticker symbol for enGene Therapeutics Inc. - Common Stock is ENGN on the Nasdaq Stock Market
What is the current price of enGene Therapeutics Inc. - Common Stock?
The current price of enGene Therapeutics Inc. - Common Stock is 1.670
When was enGene Therapeutics Inc. - Common Stock last traded?
The last trade of enGene Therapeutics Inc. - Common Stock was at 10/16/26 01:07 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
| ||||||||||||||||||||||||
